cme.medlearning.de - CME Logo

Literatur

  1. Eisenberg LM, Eisenberg CA. Stem cell plasticity, cell fusion, and transdifferentiation. Birth Defects Res C Embryo Today 2003; 69:209-218.
  2. Becker AJ, Mc CE, Till JE. Cytological demonstration of the clonal nature of spleen colonies derived from transplanted mouse marrow cells. Nature 1963; 197:452-454.
  3. Siminovitch L, McCulloch EA, Till JE. The Distribution of Colony-Forming Cells among Spleen Colonies. J Cell Physiol 1963; 62:327-336.
  4. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981; 292:154-156.
  5. Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A 1981; 78:7634-7638.
  6. Gluckman E, Broxmeyer HA, Auerbach AD, et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 1989; 321:1174-1178.
  7. Campbell KH, McWhir J, Ritchie WA, Wilmut I. Sheep cloned by nuclear transfer from a cultured cell line. Nature 1996; 380:64-66.
  8. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282:1145-1147.
  9. Mannel M. Vom Abfallprodukt zum begehrten Rohstoff - Nabelschnurblut als Quelle autologer Stammzellen für regenerative Therapieverfahren. gyn 2004; 9:1-5.
  10. Mitalipova M, al. e. Preserving the genetic integrity of human embryonic stem cells. Nature Biotechnology 2005; 23:19-20.
  11. Hoffmann LM, al. e. Characterization and culture of human embryonic stem cells. Nature Biotechnology 2005; 23:699-708.
  12. Andrews PW, Matin MM, Bahrami AR, Damjanov I, Gokhale P, Draper JS. Embryonic stem (ES) cells and embryonal carcinoma (EC) cells: opposite sides of the same coin. Biochem Soc Trans 2005; 33:1526-1530.
  13. Morrison SJ, Kimble J. Asymmetric and symmetric stem-cell divisions in development and cancer. Nature 2006; 441:1068-1074.
  14. Koestenbauer S, Zech NH, Dohr G. Trans-Differenzierung von adulten Stammzellen - Ist eine Veränderung in Richtung naiverer Zellen möglich? Journal für Reproduktionsmedizin und Endokrinologie 2006; 3:324-330.
  15. Spradling A, Drummond-Barbosa D, Kai T. Stem cells find their niche. Nature 2001; 414:98-104.
  16. Möhle R, Kanz L. Hematopoietic growth factors for hematopoietic stem cell mobilization and expansion. Semin Hematol 2007; in press.
  17. Scadden DT. The stem-cell niche as an entity of action. Nature 2006; 441:1075-1079.
  18. Yamashita YM, Mahowald AP, Perlin JR, Fuller MT. Asymmetric inheritance of mother versus daughter centrosome in stem cell division. Science 2007; 315:518-521.
  19. Pipes BL, Tsang T, Peng SX, Fiederlein R, Graham M, Harris DT. Telomere length changes after umbilical cord blood transplant. Transfusion 2006; 46:1038-1043.
  20. Engelhardt M, Deschler B, Müller C, Lübbert M. Plastizität adulter Stammzellen: Wunschtraum oder Realität? Deutsches Ärzteblatt 2003; 100:3236-3244.
  21. Alison MR, Poulsom R, Jeffery R, et al. Hepatocytes from non-hepatic adult stem cells. Nature 2000; 406:257.
  22. Gunsilius E, Duba HC, Petzer AL, et al. Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells. Lancet 2000; 355:1688-1691.
  23. Kleeberger W, Rothamel T, Glockner S, Flemming P, Lehmann U, Kreipe H. High frequency of epithelial chimerism in liver transplants demonstrated by microdissection and STR-analysis. Hepatology 2002; 35:110-116.
  24. Korbling M, Katz RL, Khanna A, et al. Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells. N Engl J Med 2002; 346:738-746.
  25. Holzgreve W. Welche Bedeutung haben Stammzellen aus Nabelschnurblut? Frauenarzt 2005; 46:666-667.
  26. Gratwohl A, Baldomero H, Frauendorfer K, Urbano-Ispizua A, Niederwieser D. Results of the EBMT activity survey 2005 on haematopoietic stem cell transplantation: focus on increasing use of unrelated donors. Bone Marrow Transplant 2007; 39:71-87.
  27. Hill JM, Zalos G, Halcox JP, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348:593-600.
  28. Tepper OM, Galiano RD, Capla JM, et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002; 106:2781-2786.
  29. Stamm C, Westphal B, Kleine HD, et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 2003; 361:45-46.
  30. Kabelitz D, Hermeler H. Potenzial von Stammzellen für die Behandlung von Autoimmunerkrankungen. Deutsches Ärzteblatt 2003; 100:A1943-1944.
  31. Cebotari S, Lichtenberg A, Tudorache I, et al. Clinical application of tissue engineered human heart valves using autologous progenitor cells. Circulation 2006; 114:I132-137.
  32. Dekel B, Burakova T, Arditti FD, et al. Human and porcine early kidney precursors as a new source for transplantation. Nat Med 2003; 9:53-60.
  33. Wiedemann PM, Simon J, Schicktanz S, Tannert C. The future of stem-cell research in Germany. A Delphi study. EMBO Rep 2004; 5:927-931.